Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study

Abstract Relapse remains the main cause of treatment failure in patients with myeloid malignancies even after allogeneic hematopoietic stem cell transplantation (allo‐HSCT). We observed a particularly low incidence of relapse in patients prepared with fludarabine, busulfan and melphalan in our previ...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jieling Jiang, Xiaofan Li, Dong Wu, Quanyi Lu, Kourong Miao, Houcai Wang, Xiaoping Li, Yingnian Chen, Shiyuan Zhou, Yali Zhou, Guiping Liao, Chuanhe Jiang, Xiaohong Yuan, Youshan Zhao, Chunkang Chang, Jie Chen, Han Zhu, Ruye Ma, Nainong Li, Xiaolin Yin, Xiaojin Wu, Sanbin Wang, Chun Wang, Jiong Hu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-08-01
Serie:	eJHaem
Soggetti:	allogeneic hematopoietic stem cell transplantation busulfan melphalan myeloid malignancies
Accesso online:	https://doi.org/10.1002/jha2.947
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!